1. Wang P, Liu Y2, Ren L*（corresponding  author）. Evaluation of left ventricular function after percutaneous recanalization of chronic coronary occlusions : The role of two-dimensional speckle tracking echocardiography. Herz. 2018 Jan 16. doi: 10.1007/s00059-017-4663-1.

2. Wang Z, Ren L, Liu N, Peng J*（corresponding  author）. Utility of Hematological Parameters in Predicting No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction. Clin Appl Thromb Hemost. 2018 Jan 1: 1076029618761005.

3. Wang Z, Liu N, Ren L, Lei L, Ye H, Peng J*（corresponding  author）. Association of Monocyte Count on Admission with the Angiographic Thrombus Burden in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Arq Bras Cardiol. 2018 Mar 12; 110(4):333-338.

4. Wang Z, Ren L, Liu N, Peng J*（corresponding  author）. The relationship between post-procedural platelet count and left ventricular aneurysm in patients with acute anterior ST-segment elevation myocardial infarction following primary percutaneous coronary intervention. Kardiol Pol. 2018;76(5):899-907.

5. Zhang X, Zhang Z, Zhao Y, Jiang N, Qiu J, Yang Y, Li J, Liang X, Wang X, Tse G, Li G*（corresponding  author）, Liu T. Alogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Alleviates Atrial Remodeling and Improves Mitochondrial Function and Biogenesis in Diabetic Rabbits. J Am Heart Assoc, 2017, 6(5). e005945.

6. Qiu J, Zhao J, Li J, Liang X, Yang Y, Zhang Z, Zhang X, Fu H, Korantzopoulos P, Tse G, Liu T, Li G*（corresponding  author）. Apocynin attenuates left ventricular remodeling in diabetic rabbits. Oncotarget. 2017, 8(24): 38482-38490.

7. Li J, Liang X, Wang Y, Xu Z, Li G*（corresponding  author）. Highly expressed PCSK9 in the atherosclerotic plaques and apoptosis of endothelial cells induced by ox-LDL. Molecular Medicine Reports, 2017, 16: 1817-1825.

8. Shi W, Shangguan W, Zhang Y, Li C, Li G*（corresponding  author）. Effects of trimetazidine on mitochondrial respiratory function, biosynthesis, and fission/fusion in rats with acute myocardial ischemia. Anatolian Journal of Cardiology, 2017, 18(3): 175-181.

9. Shangguan W, Shi W, Li G, Wang Y, Li J, Wang X. Angiotensin-(1-7) attenuates atrial tachycardia- induced sympathetic nerve remodeling. J Renin Angiotensin Aldosterone Syst. 2017 Jul-Sep;18(3):1470320317729281.

10. Ren L, Wang P, Wang 1, Liu Y, Lv S. Hypotonic contrast media is more toxic than isotonic contrast media on endothelial cells in vivo and in vitro. Mol Med Rep. 2017 Oct;16(4):4334-4340.

11. Wang Z, Ren L, Liu N, Lei L, Ye H, Peng J*（corresponding  author）. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Kardiol Pol. 2016;74(10):1160-1166.

12. Chen C, Jia KY, Zhang HL, Fu J. MiR-195 enhances cardiomyocyte apoptosis induced by hypoxia/reoxygenation injury via downregulating c-myb. Eur Rev Med Pharmacol Sci. 2016 Aug;20(16):3410-6.    

13. Wang Z, Ren L, Lei L, Ye H, Peng J*（corresponding  author）. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol. 2016 Apr;71(2):241-6.

14. Xu G, Cui Y, Jia Z, Yue Y, Yang S. The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation.  PLoS One. 2016 Nov 17;11(11):e0166235.

15. Zhao B1, Peng J*（corresponding  author）, Ren L, Lei L, Wang Z, Ye H. Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction. Exp Ther Med. 2016, Dec;12(6):4147-4153.

16. Wang XH, Li GP*（corresponding  author）, Yang WS, Jiao ZQ, Liu HM, Ni YP. Cardioprotective effects of traditional Chinese medicine Guanmaitong on acute myocardial infarction. Exp Ther Med, 2016, 12(6): 3927–3933.

17. Zhao ZQ, Liu T, Zhu XT, Cui L, Fan C, Zhang XW, Li GP*（corresponding  author）. Epicardial or transvenous leads: Comtroversial for the placement in implantation of cardiac resynchro- nization therapy. Int J Cardiol, 2016, 202:834-835.

18. Zhao Z, Chen Y, Li W, Wang X, Li J, Yang W, Cheng L, Liu T, Liu E, Li GP*（corresponding  author）. Aliskiren protecting atrial remodeling from rapid atrial pacing in Canine model. Naunyn Schmiedebergs Arch Pharmacol. 2016 Aug;389(8):863-71.

19. Xu LX, Chen KY, Liu T, Zheng XT, Jiao ZQ, Xu Y, Li G*（corresponding  author）. Adjunctive loading dose of cilostazol in preventing periprocedural myocardial infarction. Cardiovasc Ther, 2016, 34(4): 225-33.

20. Qiu J, Zhao J, Li J, Liang X, Yang Y, Zhang Z, Zhang X, Fu H, Korantzopoulos P, Liu T, Li G *（corresponding  author）. NADPH oxidase inhibitor apocinin prevents atrial remodeling in alloxan-induecd diabetic rabbits. Inter J Cardiol, 2016, 221: 812-9.

21. Zhao Z, Wang Y, Chen Y, Wang X, Li J, Yuan M, Liu T, Li G *（corresponding  author）. Cilostazol Prevents Atrial Structural Remodeling through the MEK/ERK Pathway in a Canine Model of Atrial Tachycardia. Cardiology, 2016, 135: 240-248.

22. Li J, Yang Y, Ng CY, Zhang Z, Liu T, Li G *（corresponding  author）. Association of Plasma Transforming Growth Factor- β1Levels and the Risk of Atrial Fibrillation: A Meta-Analysis. PLoS One, 2016, 11(5): e0155275.

23. Zhang E, Li Z, Che J, Chen X, Qin T, Tong Q, Zhao W, Li G *（corresponding  author）. Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction. Am J Med Sci. 2015 Jun;349(6):493-8. doi: 10.1097/MAJ.0000000000000471.

24. Shao Q, Chen K, Rha SW, Lim HE, Li G *（corresponding  author）, Liu T. Usefulness of Neutrophil Lymphocyte Ratio as a Predictor of Atrial Fibrillation: A Meta- analysis. Arch Med Res. 2015, 46(3): 199- 06.

25. Yue Y, Wang L, Yang N, Huang J, Lei L, Ye H, Ren L, Yang S. Effectiveness of biodegradable magnesium alloy stents in coronary artery and femoral artery. J Interv Cardiol. 2015 Aug;28(4):358-64.

26. Jiao Z, Chen J, Liu Y, Liu T, Chen K, Li G *（corresponding  author）. Role of ERK1/2 and JNK hosphorylation in iodine contrast agent-induced apoptosis in diabetic rat kidneys. Renal Fail, 2015, 37(8):1349-55.

27. 王萍, 劉勇, 侯淑鳳, 葉慧明, 劉穎萍, 任利輝. 應用二維斑點追蹤顯像技術(shù)評價冠狀動脈慢性閉塞患者冠狀動脈介入治療前后左心功能的價值. 中國循環(huán)雜志. 2017, 32 (1):50-53.

28. 趙晟, 姚小燕, 薛新穎, 高培良, 鄧會, 張婧媛, 潘磊, 王勇. 低壓低氧性肺動脈高壓中組織因子致高凝狀態(tài)的研究. 中國分子心臟病學雜志. 2016 (6):1920-1922.

29. 徐桂玉, 趙楠楠, 楊水祥. 房顫射頻消融術(shù)逆轉(zhuǎn)冠狀竇血miRNA異常表達的研究. 中國心血管病研究雜志. 2016, 14(8),720-726.

30. 王佐巖. 聯(lián)合應用PPT及傳統(tǒng)板書在住院醫(yī)師心電圖培訓中教學效果的研究. 繼續(xù)醫(yī)學教育. 2015 (9) :7-8.

31. 關付, 葉慧明, 彭建軍, 任利輝, 雷力成, 楊水祥. 非瓣膜性心房顫動患者冠狀動脈造影的結(jié)果分析. 中國心血管雜志. 2015 (3):185-187.

32. 關付, 彭建軍, 任利輝, 葉慧明, 雷力成, 趙楠楠, 楊水祥, 王福財. 經(jīng)皮冠狀動脈介入術(shù)對NSTE-ACS患者校正后QTc-d和JTc-d的影響. 中國老年學雜志. 2015 9(14):3891-3893.

33. 趙博, 彭建軍. 從新指南看非ST段抬高急性冠脈綜合征患者的抗栓治療. 中國臨床醫(yī)生雜志. 2015(5):9-12. 

34. 趙楠楠, 劉穎萍, 王志男, 晉斌, 王萍, 楊水祥, 任利輝. 他汀類藥物對慢性心力衰竭的療效. 武警醫(yī)學. 2015 , 26 (6) : 606-608.

35. 趙楠楠, 徐郡玲, 楊水祥. 伊伐布雷定治療慢性穩(wěn)定型心絞痛的臨床療效觀察. 中國心血管病研究. 2015 , 13 (3) : 241-244.

36. 王汝朋, 楊水祥. 利伐沙班和達比加群酯及華法林在非瓣膜性心房顫動患者抗凝治療的研究. 中華老年心腦血管病雜志. 2015,17(12):1246-1249.

37. 王汝朋, 楊水祥. 可吸收鎂合金支架植入后犬冠狀動脈C-反應蛋白、基質(zhì)金屬蛋白酶9和血管性血友病因子的表達. 中國組織工程研究. 2015,19(8):1216-1222.

38. 陳策, 彭建軍. 老年急性心肌梗死患者直接冠狀動脈介入治療同時給予高劑量替羅非班的安全性及療效. 中國老年學雜志. 2015 , 35 (22) :6396-6398.

39. 王萍, 劉穎萍, 王佐巖, 王志男, 趙楠楠, 葉慧明, 任利輝. 瑞舒伐他汀對高膽固醇血癥患者動脈僵硬度的影響. 中華醫(yī)學雜志. 2014 (31) :2452-2454.